ROS trigger many signaling pathways in cancer cells to affect cell growth, differentiation, protein synthesis, glucose metabolism and survival pathways including MAPK/ERK, PI3K/Akt and IKK/NF-κB signaling pathways [42,43]. This evidence concerns the gene AKT1 and cancer.